Metabolic memory underlying minimal residual disease in breast cancer
Abstract Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi‐omics data from a tractable organoid system with a...
Guardado en:
Autores principales: | Ksenija Radic Shechter, Eleni Kafkia, Katharina Zirngibl, Sylwia Gawrzak, Ashna Alladin, Daniel Machado, Christian Lüchtenborg, Daniel C Sévin, Britta Brügger, Kiran R Patil, Martin Jechlinger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0276c0d71bf4b688df33f54bc4ee1f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
por: Hannah K. Hopkins, et al.
Publicado: (2021) -
Mutación del gen BRAF en pacientes con cánceres de colon y recto con KRAS no mutado
por: Roa,Iván, et al.
Publicado: (2014) -
Current Status of Breast Organoid Models
por: Srivarshini Cherukupalli Mohan, et al.
Publicado: (2021) -
Oncogene
Publicado: (1987) -
Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
por: Jin Won Kim, et al.
Publicado: (2021)